Godfrey Financial Associates, Inc.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 2097943
GLENMONT, NY
Position in ACAD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,492
+$179 QoQ
Shares Held
59
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#324
of 350 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Godfrey Financial Associates, Inc. holds $26,094 across 15 Biotechnology names. ACAD ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GPCR |
Structure Therapeutics Inc.
|
245 | $13,149 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
29 | $2,365 | |
| 3 | MRNA |
Moderna, Inc.
|
26 | $1,820 | |
| 4 | INVA |
Innoviva, Inc.
|
78 | $1,771 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
59 | $1,492 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
6 | $1,445 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
32 | $1,132 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1 | $623 |
All Filings in ACAD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,492 | 59 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,313 | 59 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,575 | 59 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||